XBiotech Faces Class Action Over Drug Study Problems
XBiotech Inc. was hit with a putative class action in California state court by a group of shareholders who invested in the pharmaceutical company following its initial public offering, claiming the...To view the full article, register now.
Already a subscriber? Click here to view full article